Home › Targets › SSTR2

SSTR2 (1 companies · 2 programs)

Companies with an active program directed at SSTR2.

Perspective Therapeutics, Inc. CATX

VMT-α-NET — Neuroendocrine Tumors Phase 1
VMT-α-NET — Meningioma Phase 1